title: Prostate cancer treatment: the times they are a' changin'.
authors.affiliation: The Prostate Centre, London, UK.
authors.forename: Roger
authors.initials: R
authors.lastname: Kirby
authors.forename: Ben
authors.initials: B
authors.lastname: Challacombe
authors.forename: Prokar
authors.initials: P
authors.lastname: Dasgupta
authors.forename: John M
authors.initials: JM
authors.lastname: Fitzpatrick
mesh_terms: D000069501:Abiraterone Acetate; D000730:Androstadienes / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D019496:Cancer Vaccines / Q000627:therapeutic use; D006801:Humans; D008297:Male; D060787:Neoplasm Grading; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D043823:Taxoids / Q000627:therapeutic use; D014020:Tissue Extracts / Q000627:therapeutic use
chemical_list: D000730:Androstadienes; D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D043823:Taxoids; D014020:Tissue Extracts; C552428:cabazitaxel; C511774:sipuleucel-T; D000069501:Abiraterone Acetate